iDECIDE: A Mobile Application for Insulin Dosing Using an Evidence Based Equation to Account for Patient Preferences.
Diabetes is a complex disease affecting 29.1 million (9.3%) US citizens [1]. It is a chronic illness that needs continual medical care and ongoing patient self-management, education, and support [2]. There is no cure for diabetes, requiring patients to conduct frequent self-monitoring of blood glucose and dosing of insulin in many cases. Evidence has shown that patients are more adherent to their diabetes management plan when they incorporate personal lifestyle choices [3]. To address the challenge of empowering patients to better manage their diabetes, we have developed a novel mobile application prototype, iDECIDE, that refines rapid-acting insulin dose calculations by incorporating two important patient variables in addition to carbohydrates consumed that are not a part of standard insulin dose calculation algorithms: exercise and alcohol intake [4, 5]. A retrospective analysis for the calibration and evaluation of iDECIDE is underway by comparing recommendations made by the application against dosing recommendations made by insulin pumps.
Arizona State University Department of Biomedical Informatics, AZ.
Buffy
B
Lloyd
Arizona State University Department of Biomedical Informatics, AZ.
Danielle
D
Groat
Arizona State University Department of Biomedical Informatics, AZ.
Curtiss B
CB
Cook
Arizona State University Department of Biomedical Informatics, AZ.
David
D
Kaufman
Arizona State University Department of Biomedical Informatics, AZ.
Adela
A
Grando
D003198:Computer Simulation; D020000:Decision Support Systems, Clinical / Q000458:organization & administration*; D003922:Diabetes Mellitus, Type 1 / Q000175:diagnosis* / Q000188:drug therapy*; D004360:Drug Therapy, Computer-Assisted / Q000379:methods*; D019317:Evidence-Based Medicine; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage; D007328:Insulin / Q000008:administration & dosage*; D063731:Mobile Applications; D008954:Models, Biological; D057240:Patient Preference; D012646:Self Administration / Q000379:methods; D014481:United States; D014584:User-Computer Interface
D007004:Hypoglycemic Agents; D007328:Insulin